|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 15681814 | p53 | p53 | 1.4 | New therapeutic strategies and drug candidates for neurodegenerative diseases p53 and TNF-alpha inhibitors and GLP-1 receptor agonists | |  |
| 15681814 | p53 | p53 | 1.4 | Such targets include TNF-alpha p53 and GLP-1 receptor | | |
| 15681814 | p53 | p53 | 1.4 | The intracellular protein and transcription factor p53 is activated by the Alzheimer's disease toxic peptide Abeta as | | |
| 16104843 | p53 | p53 | 0.3 | a variety of stimuli such as hypoxia growth factors transformation p53 mutation oestrogen TSH (thyroid-stimulating thyroid-stimulating hormone tumour promoters and NO | | |
| 17191135 | p53 | p53 | 0.6 | factors such as the AP-1 family members NF-kB Jun Fos p53 CREB PEBP2/CBF, PEBP2 CBF Myb all involved in fundamental processes | | |